Immune System News and Research

RSS

Salmonella infections can reduce incidence of asthma, say researchers

Researchers from Germany have identified the mechanism by which Salmonella infections can reduce the incidence of asthma in mice. The research, which appears ahead of print in the journal Infection and Immunity, opens up new avenues of research that could lead to treatments.

24 Jan 2014

Sexual selection enhances ability of offspring to cope with infection

To test whether female mate choice enhances the health and disease-resistance of offspring, either through immune resistance, tolerance to infection, or both, researchers led by Dustin Penn tested female house mice's preferences (Mus musculus) for particular males and then experimentally assigned each female to mate with either their preferred or their non-preferred male.

24 Jan 2014

BRI receives grant to lead ITN for evaluating novel therapies for transplantation, allergy and autoimmune diseases

The National Institutes of Health has awarded Benaroya Research Institute at Virginia Mason a 7-year grant to lead the Immune Tolerance Network.

24 Jan 2014

Loyola professor receives prestigious Presidential Early Career Award for Scientists and Engineers

Katherine Radek, PhD, of Loyola University Chicago Stritch School of Medicine, has received a prestigious Presidential Early Career Award for Scientists and Engineers.

24 Jan 2014

Human body odor contains an early chemosensory cue of sickness

Humans are able to smell sickness in someone whose immune system is highly active within just a few hours of exposure to a toxin, according to new research published in Psychological Science, a journal of the Association for Psychological Science.

24 Jan 2014

CytRx initiates aldoxorubicin Phase 2 trial in HIV-infected patients with Kaposi's sarcoma

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a Phase 2 clinical trial to determine preliminary efficacy and safety of aldoxorubicin for HIV-infected patients with Kaposi's sarcoma.

23 Jan 2014

Inovio Pharmaceuticals unveils new DNA-based cytokine immune activator

Inovio Pharmaceuticals, Inc. today unveiled that the company has developed a new DNA-based cytokine immune activator, interleukin -33 (IL-33), that in combination with optimized DNA vaccines delivered by electroporation increased the potency and efficacy of the therapeutic response to the DNA vaccines in a preclinical study.

23 Jan 2014

New heart tissue could help patients suffering from irreparable damage

In the U.S., someone suffers a heart attack every 34 seconds - their heart is starved of oxygen and suffers irreparable damage. Engineering new heart tissue in the laboratory that could eventually be implanted into patients could help, and scientists are reporting a promising approach tested with rat cells.

23 Jan 2014

Personalized vaccine therapy contributes to increased survival rate in IL2-treated metastatic melanoma

Metastatic melanoma has a poor prognosis, but treatment with high-dose interleukin-2 (IL2) can extend survival. Now, a combination of IL2 therapy and activation of patients' immune systems using personalized vaccines made from their own tumor cells has been shown to improve survival rates even more than IL2 alone, according to a new article in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

23 Jan 2014

New injectable material delivers drug therapies and sensor technology to targeted areas in human body

A new injectable material designed to deliver drug therapies and sensor technology to targeted areas within the human body is being developed by a Texas A&M University biomedical engineer who says the system can lock its payload in place and control how it is released.

23 Jan 2014

MD Anderson collaborates with Johnson & Johnson to develop immunology-based cancer treatments

The University of Texas MD Anderson Cancer Center will collaborate with Johnson & Johnson Innovation, LLC, and its affiliate Janssen Biotech, Inc., to develop immunology-based cancer treatments through the MD Anderson Moon Shots Program immunotherapy platform.

23 Jan 2014

Scientists give cautious welcome for new types of drug intended for use in place of antibiotics

New types of drug intended for use in place of antibiotics have been given a cautious welcome by scientists.

23 Jan 2014

NPS MedicineWise urges parents to ensure that children's vaccinations are up to date

Following a recent spate of measles cases being reported in a number of Australian states, NPS MedicineWise is reminding parents to check whether their children’s immunisations are up to date before they head back to school next week.

22 Jan 2014

Blood methylome offers clues to schizophrenia

Researchers show that a methylome-wide association study of the blood can provide a glimpse of past environmental insults that may contribute to the development of schizophrenia.

22 Jan 2014

Advanced melanoma treatments: an interview with Dr. James Larkin, Consultant Medical Oncologist, The Royal Marsden

Advanced melanoma affects around 2,000 people per year in the UK. Advanced melanoma describes a melanoma that has spread from its site of origin to other areas of the body.

22 Jan 2014

Scientists showcase HDL nanotherapy that may provide solution to repeat heart attacks

Up to 30 percent of heart attack patients suffer a new heart attack because cardiologists are unable to control inflammation inside heart arteries - the process that leads to clots rupturing and causing myocardial infarction or stroke.

22 Jan 2014

Adding quinoa to gluten-free diet of patients with celiac disease is well-tolerated

Adding quinoa to the gluten-free diet of patients with celiac disease is well-tolerated, and does not exacerbate the condition, according to new research published in The American Journal of Gastroenterology. Dr. Victor F. Zevallos, from the Department of Gastroenterology, King's College London, United Kingdom, evaluated the in-vivo effects of consuming quinoa in adult celiac patients. Quinoa, a highly nutritious grain, is traditionally recommended as part of a gluten-free diet.

22 Jan 2014

Swedish study confirms H1N1 vaccinations show increased risk of narcolepsy in children, adolescents

Pandemrix is an influenza vaccination, created in 2009 to combat H1N1, known as Swine Flu. Now, a team of Swedish clinicians testing the vaccine for links to immune-related or neurological diseases have linked Pandemrix to an increased risk of narcolepsy in young adults.

21 Jan 2014

African-American women with high levels of depressive symptoms have greater likelihood of adult-onset asthma

According to a new study from the Slone Epidemiology Center (SEC) at Boston University, African-American women who reported high levels of depressive symptoms had a greater likelihood of adult-onset asthma compared to women who reported fewer depressive symptoms.

21 Jan 2014

Levels of depression and anxiety are higher in people with severe rheumatoid arthritis

Levels of depression and anxiety in people with severe rheumatoid arthritis are higher than previously reported, according to new research. As a result of their findings, a multi-centre team led by researchers at the Arthritis Research UK Centre for Genetics and Genomics at the University of Manchester, say that patients with severe active disease, who are waiting to go onto a biological therapy, should be routinely screened for depression by their doctors.

From The University of Manchester 21 Jan 2014

Immune System News and Research

Salmonella infections can reduce incidence of asthma, say researchers

Sexual selection enhances ability of offspring to cope with infection

BRI receives grant to lead ITN for evaluating novel therapies for transplantation, allergy and autoimmune diseases

Loyola professor receives prestigious Presidential Early Career Award for Scientists and Engineers

Human body odor contains an early chemosensory cue of sickness

CytRx initiates aldoxorubicin Phase 2 trial in HIV-infected patients with Kaposi's sarcoma

Inovio Pharmaceuticals unveils new DNA-based cytokine immune activator

New heart tissue could help patients suffering from irreparable damage

Personalized vaccine therapy contributes to increased survival rate in IL2-treated metastatic melanoma

New injectable material delivers drug therapies and sensor technology to targeted areas in human body

MD Anderson collaborates with Johnson & Johnson to develop immunology-based cancer treatments

Scientists give cautious welcome for new types of drug intended for use in place of antibiotics

NPS MedicineWise urges parents to ensure that children's vaccinations are up to date

Blood methylome offers clues to schizophrenia

Advanced melanoma treatments: an interview with Dr. James Larkin, Consultant Medical Oncologist, The Royal Marsden

Scientists showcase HDL nanotherapy that may provide solution to repeat heart attacks

Adding quinoa to gluten-free diet of patients with celiac disease is well-tolerated

Swedish study confirms H1N1 vaccinations show increased risk of narcolepsy in children, adolescents

African-American women with high levels of depressive symptoms have greater likelihood of adult-onset asthma

Levels of depression and anxiety are higher in people with severe rheumatoid arthritis

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News